Knockdown of hypoxia-inducible factor 1-alpha (HIF1α) interferes with angiopoietin-like protein 2 (ANGPTL2) to attenuate high glucose-triggered hypoxia/reoxygenation injury in cardiomyocytes

References

• Di Angelantonio E, Thompson A, Wensley F, et al. Coronary heart disease. IARC scientific publications. 2011;(163):363–386.
   PubMedGoogle Scholar
• Saito I, Yamagishi K, Kokubo Y, et al. Association between mortality and incidence rates of coronary heart disease and stroke: the Japan Public Health Center-based prospective (JPHC) study. Int J Cardiol. 2016;222:281–286.
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.
   PubMed Web of Science ®Google Scholar
• Bin Z, Qian M, M F-Z, et al. Astragaloside Ⅳ’s therapeutic effect on myocardial infarction via affecting autophagy and the mechanism study. Journal of Sichuan University (Medical science edition). 2021;52(2):222–228.
   Google Scholar
• Neri M, Riezzo I, Pascale N, et al. Ischemia/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists. Mediators Inflamm. 2017;2017:7018393.
   PubMed Web of Science ®Google Scholar
• Ibanez B, Macaya C, Sánchez-Brunete V, et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial. Circulation. 2013;128(14):1495–1503.
   PubMed Web of Science ®Google Scholar
• Tibaut M, Mekis D, Petrovic D. Pathophysiology of myocardial infarction and acute management strategies. Cardiovasc Hematol Agents Med Chem. 2017;14(3):150–159.
   PubMedGoogle Scholar
• Hausenloy DJ, Chilian W, Crea F, et al. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. Cardiovasc Res. 2019;115(7):1143–1155.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics committee and stroke statistics subcommittee. Circulation. 2009;119(3):480–486.
   PubMed Web of Science ®Google Scholar
• Crandall JP, Shamoon H, Cohen HW, et al. Post-challenge hyperglycemia in older adults is associated with increased cardiovascular risk profile. J Clin Endocrinol Metab. 2009;94(5):1595–1601.
   PubMed Web of Science ®Google Scholar
• Lin HJ, Lee BC, Ho YL, et al. Postprandial glucose improves the risk prediction of cardiovascular death beyond the metabolic syndrome in the nondiabetic population. Diabetes Care. 2009;32(9):1721–1726.
   PubMed Web of Science ®Google Scholar
• Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006;83(6):1237–1247.
   PubMed Web of Science ®Google Scholar
• Lteif AA, Mather KJ, Clark CM. Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes. Cardiol Rev. 2003;11(5):262–274.
   PubMedGoogle Scholar
• Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–234.
   PubMed Web of Science ®Google Scholar
• Kadomatsu T, Endo M, Miyata K, et al. Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol Metab. 2014;25(5):245–254.
   PubMed Web of Science ®Google Scholar
• Horio E, Kadomatsu T, Miyata K, et al. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol. 2014;34(4):790–800.
   PubMed Web of Science ®Google Scholar
• Tabata M, Kadomatsu T, Fukuhara S, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab. 2009;10(3):178–188.
   PubMed Web of Science ®Google Scholar
• Kadomatsu T, Tabata M, Oike Y. Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases. FEBS J. 2011;278(4):559–564.
   PubMed Web of Science ®Google Scholar
• Aoi J, Endo M, Kadomatsu T, et al. Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res. 2011;71(24):7502–7512.
   PubMed Web of Science ®Google Scholar
• Endo M, Nakano M, Kadomatsu T, et al. Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res. 2012;72(7):1784–1794.
   PubMed Web of Science ®Google Scholar
• Okada T, Tsukano H, Endo M, et al. Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol. 2010;176(5):2309–2319.
   PubMed Web of Science ®Google Scholar
• Caland L, Labbé P, Mamarbachi M, et al. Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice. Aging (Albany NY). 2019;11(11):3832–3850.
   PubMedGoogle Scholar
• Jiao L, Zhuang Y, Jiang M, et al. Angiopoietin-like 2 has auxo-action in atherosclerosis by promoting atherosclerotic calcification. Int J Clin Exp Pathol. 2017;10(8):9084–9091.
   PubMed Web of Science ®Google Scholar
• Gellen B, Thorin-Trescases N, Sosner P, et al. ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients. Diabetologia. 2016;59(11):2321–2330.
   PubMed Web of Science ®Google Scholar
• Yichao WU, Liu Z, Zeng C, et al. Glomerular gene expression profiles in patients with diabetic nephropathy. Chinese Journal of Nephrology Dialysis & Transplantion. 2004;13(6): 503–511.
   Google Scholar
• Li Q, Gong W, Yang Z, et al. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes. Diabetes Res Clin Pract. 2013;100(3):385–390.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu D, Hu H, et al. HIF-1α/BNIP3 signaling pathway-induced-autophagy plays protective role during myocardial ischemia-reperfusion injury. Biomed Pharmacother. 2019;120:109464.
   PubMed Web of Science ®Google Scholar
• Li J, Yuan YQ, Zhang L, et al. Exogenous hydrogen sulfide protects against high glucose-induced apoptosis and oxidative stress by inhibiting the STAT3/HIF-1α pathway in H9c2 cardiomyocytes. Exp Ther Med. 2019;18(5):3948–3958.
   PubMed Web of Science ®Google Scholar
• Pu J, Zhu S, Zhou D, et al. Propofol alleviates apoptosis induced by chronic high glucose exposure via regulation of HIF-1α in H9c2 cells. Oxid Med Cell Longev. 2019;2019:4824035.
   PubMed Web of Science ®Google Scholar
• Zhu ZY, Wang F, Jia CH, et al. Apigenin-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngII/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells. Phytomedicine. 2019;62:152713.
   PubMed Web of Science ®Google Scholar
• Leng J, Li X, Tian H, et al. Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the Nrf2/HO-1 pathway. BMC complementary medicine and therapies. 2020;20(1):126.
   PubMedGoogle Scholar
• Yang MY, Fan Z, Zhang Z, et al. MitoQ protects against high glucose-induced brain microvascular endothelial cells injury via the Nrf2/HO-1 pathway. J Pharmacol Sci. 2021;145(1):105–114.
   PubMed Web of Science ®Google Scholar
• Kosuru R, Kandula V, Rai U, et al. Pterostilbene decreases cardiac oxidative stress and inflammation via activation of AMPK/Nrf2/HO-1 pathway in fructose-fed diabetic rats. Cardiovasc Drugs Ther. 2018;32(2):147–163.
   PubMed Web of Science ®Google Scholar
• Xiang H, Xue W, Li Y, et al. Knockdown of ANGPTL2 protects renal tubular epithelial cells against hypoxia/reoxygenation-induced injury via suppressing TLR4/NF-κb signaling pathway and activating Nrf2/HO-1 signaling pathway. Cell Transplant. 2020;29:963689720946663.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xia ZY, Zhao B, et al. (-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions. Int J Mol Med. 2017;40(2):389–399.
   PubMed Web of Science ®Google Scholar
• Zheng W, Li T, Wei J, et al. Identification of miR-145 as a regulator of the cardiomyocyte inflammatory response and oxidative stress under hyperglycemia. Exp Ther Med. 2021;21(5):467.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Yang X, Jiang J, Zhang C, et al. Baicalein restrains proliferation, migration, and invasion of human malignant melanoma cells by down-regulating colon cancer associated transcript-1. Braz J Med Biol Res = Rev Bras Pesqui Med Biol. 2019;52(12):e8934.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang Y, Hu K, et al. HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p. Cell Death Dis. 2020;11(3):176.
   PubMed Web of Science ®Google Scholar
• Noman MZ, Desantis G, Janji B, et al. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211(5):781–790.
   PubMed Web of Science ®Google Scholar
• Amini N, Sarkaki A, Dianat M, et al. Protective effects of naringin and trimetazidine on remote effect of acute renal injury on oxidative stress and myocardial injury through Nrf-2 regulation. Pharmacol Rep. 2019;71(6):1059–1066.
   PubMed Web of Science ®Google Scholar
• Liu L, Gan S, Li B, et al. Fisetin alleviates atrial inflammation, remodeling, and vulnerability to atrial fibrillation after myocardial infarction. Int Heart J. 2019;60(6):1398–1406.
   PubMed Web of Science ®Google Scholar
• Wung BS, Cheng JJ, Hsieh HJ, et al. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res. 1997;81(1):1–7.
   PubMed Web of Science ®Google Scholar
• De Keulenaer GW, Ushio-Fukai M, Yin Q, et al. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000;20(2):385–391.
   PubMed Web of Science ®Google Scholar
• Chandrasekar B, Mitchell DH, Colston JT, et al. Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation. 1999;99(3):427–433.
   PubMed Web of Science ®Google Scholar
• Blum A, Sclarovsky S, Rehavia E, et al. Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J. 1994;127(5):1226–1230.
   PubMed Web of Science ®Google Scholar
• Liu L. Evaluation on the levels of oxidative stress, inflammatory indices and efficacy of lyophilized recombinant human brain natriuretic peptide in patients with myocardial Ischemia. Medical Innovation of China. 2018;15(9):14–18.
   Google Scholar
• Yin Y, Han W, Cao Y. Association between activities of SOD, MDA and Na(+)-K(+)-ATPase in peripheral blood of patients with acute myocardial infarction and the complication of varying degrees of arrhythmia. Hellenic J Cardiol = Hellenike Kardiologike Epitheorese. 2019;60(6):366–371.
   PubMed Web of Science ®Google Scholar
• Evran B, Karpuzoğlu H, Develi S, et al. Effects of carnosine on prooxidant-antioxidant status in heart tissue, plasma and erythrocytes of rats with isoproterenol-induced myocardial infarction. Pharmacol Rep. 2014;66(1):81–86.
   PubMed Web of Science ®Google Scholar
• Takano M, Hirose N, Sumi C, et al. ANGPTL2 promotes inflammation via integrin α5β1 in chondrocytes. Cartilage. 2019. 1947603519878242. 10.1177/1947603519878242
   Web of Science ®Google Scholar
• Nishiyama S, Hirose N, Yanoshita M, et al. ANGPTL2 induces synovial inflammation via LILRB2. Inflammation. 2021;44(3):1108–1118.
   PubMed Web of Science ®Google Scholar
• Yang L, Li T, Zha L. Foxc2 alleviates Ox-LDL-induced lipid accumulation, inflammation, and apoptosis of macrophage via regulating the expression of Angptl2. Inflammation. 2020;43(4):1397–1410.
   PubMed Web of Science ®Google Scholar
• Yang W, Liu W, Yu W, et al. Angptl2 deficiency attenuates paraquat (PQ)-induced lung injury in mice by altering inflammation, oxidative stress and fibrosis through NF-κB pathway. Biochem Biophys Res Commun. 2018;503(1):94–101.
   PubMed Web of Science ®Google Scholar
• Oike Y, Tian Z, Miyata K, et al. ANGPTL2 - A new causal player in accelerating heart disease development in the aging. Circulation Journal Official Journal of the Japanese Circulation Society. 2017;81(10):1379–1385
   PubMed Web of Science ®Google Scholar
• Thorin-Trescases N, Thorin E. Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties. Expert Rev Mol Med. 2014;16. 10.1017/erm.2014.19
   PubMed Web of Science ®Google Scholar
• Siow RC, Ishii T, Mann GE. Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway. Redox report: communications in free radical research. 2007;12(1):11–15
   PubMed Web of Science ®Google Scholar
• Kolamunne RT, Dias IH, Vernallis AB, et al. Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species. Redox Biol. 2013;1(1):418–426.
   PubMed Web of Science ®Google Scholar
• Fourquet S, Guerois R, Biard D, et al. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation. J Biol Chem. 2010;285(11):8463–8471.
   PubMed Web of Science ®Google Scholar
• Yu H, Shi L, Zhao S, et al. Triptolide attenuates myocardial ischemia/reperfusion injuries in rats by inducing the activation of Nrf2/HO-1 defense pathway. Cardiovasc Toxicol. 2016;16(4):325–335.
   PubMed Web of Science ®Google Scholar
• Bai L, Shi W, Liu J, et al. Protective effect of pilose antler peptide on cerebral ischemia/reperfusion (I/R) injury through Nrf-2/OH-1/NF-κB pathway. Int J Biol Macromol. 2017;102:741–748.
   PubMed Web of Science ®Google Scholar
• He W, Su Q, Liang J, et al. The protective effect of nicorandil on cardiomyocyte apoptosis after coronary microembolization by activating Nrf2/HO-1 signaling pathway in rats. Biochem Biophys Res Commun. 2018;496(4):1296–1301.
   PubMed Web of Science ®Google Scholar
• Zhao SM, Gao HL, Wang YL, et al. Attenuation of high glucose-induced rat cardiomyocyte apoptosis by Exendin-4 via intervention of HO-1/Nrf-2 and the PI3K/AKT signaling pathway. Chin J Physiol. 2017;60(2):89–96.
   PubMed Web of Science ®Google Scholar
• Li H, Yao W, Irwin MG, et al. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Free Radic Biol Med. 2015;84:311–321.
   PubMed Web of Science ®Google Scholar